FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
ALDORIL 25
hydrochlorothiazide; methyldopa
LOE Approaching
Merck & Co.
ORAL · TABLET
hypertension
1962
NDA
30/100
ALDORIL D30
hydrochlorothiazide; methyldopa
LOE Approaching
Merck & Co.
ORAL · TABLET
hypertension
1962
NDA
30/100
ALDORIL D50
hydrochlorothiazide; methyldopa
LOE Approaching
Merck & Co.
ORAL · TABLET
hypertension
1962
NDA
30/100
ALESSE
ethinyl estradiol; levonorgestrel
LOE Approaching
Cadence Neuroscience
ORAL-21 · TABLET
pregnancy
1997
NDA
30/100
ALEVE
naproxen sodium
LOE Approaching
Bayer
ORAL · TABLET
minor achespains due to: minor pain of arthritis muscular aches backache menstrual cramps headache toothache the common cold temporarily reduces fever
1994
NDA
30/100
ALEVE PM
diphenhydramine hydrochloride and naproxen sodium
Peak
Bayer
ORAL · TABLET
2014
NDA
30/100
ALEVE-D SINUS & COLD
naproxen sodium; pseudoephedrine hydrochloride
LOE Approaching
Bayer
ORAL · TABLET, EXTENDED RELEASE
1999
NDA
30/100
ALFENTA
alfentanil hydrochloride
LOE Approaching
INJECTION · INJECTABLE
1986
NDA
30/100
ALIMTA
pemetrexed
LOE Approaching
Eli Lilly and Company
INJECTION · INJECTABLE
non-small cell lung cancerlung cancer
2004
NDA
30/100
ALIMTA
pemetrexed disodium
LOE Approaching
Eli Lilly and Company
INTRAVENOUS · POWDER
non-small cell lung cancerlung cancer
2004
NDA
30/100
ALINIA
nitazoxanide
LOE Approaching
Partner Therapeutics
ORAL · TABLET
diarrhea caused by Giardia lambliaCryptosporidium parvum
2004
NDA
30/100
ALINIA
nitazoxanide
LOE Approaching
Partner Therapeutics
ORAL · FOR SUSPENSION
diarrhea caused by Giardia lambliaCryptosporidium parvum
2002
NDA
30/100
ALINIA
nitazoxanide
LOE Approaching
Partner Therapeutics
ORAL · TABLET
diarrhea caused by Giardia lambliaCryptosporidium parvum
2005
NDA
30/100
ALKERAN
melphalan hydrochloride
LOE Approaching
INJECTION · INJECTABLE
myeloma
1992
NDA
30/100
ALKERAN
melphalan
LOE Approaching
ORAL · TABLET
myeloma
1964
NDA
30/100
ALLEGRA
fexofenadine hydrochloride
LOE Approaching
Sanofi
ORAL · CAPSULE
these symptoms due to hay feverother upper respiratory allergies: ▪ runny nose ▪ sneezing ▪ itchy+5
1996
NDA
30/100
ALLEGRA
fexofenadine hydrochloride
LOE Approaching
Sanofi
ORAL · SUSPENSION
these symptoms due to hay feverother upper respiratory allergies: ▪ runny nose ▪ sneezing ▪ itchy+5
2006
NDA
30/100
ALLEGRA ALLERGY
fexofenadine hydrochloride
LOE Approaching
Sanofi
ORAL · TABLET
hivesrelieves itching due to hives (urticaria)+1
2000
NDA
30/100
ALLEGRA HIVES
fexofenadine hydrochloride
LOE Approaching
Sanofi
ORAL · TABLET
hivesrelieves itching due to hives (urticaria)+1
2000
NDA
30/100
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
fexofenadine hydrochloride and pseudoephedrine hydrochloride
LOE Approaching
Sanofi
ORAL · TABLET, EXTENDED RELEASE
these symptoms due to hay feverother upper respiratory allergies: ▪ runny nose ▪ sneezing ▪ itchy+5
1997
NDA
30/100
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION
fexofenadine hydrochloride and pseudoephedrine hydrochloride
LOE Approaching
Sanofi
ORAL · TABLET, EXTENDED RELEASE
these symptoms due to hay feverother upper respiratory allergies: ▪ runny nose ▪ sneezing ▪ itchy+5
2004
NDA
30/100
ALLERNAZE
triamcinolone acetonide
LOE Approaching
NASAL · SPRAY, METERED
the nasal symptoms of seasonalperennial allergic rhinitis in adults+2
2000
NDA
30/100
ALLI
orlistat
LOE Approaching
GSK
ORAL · CAPSULE
2007
SMNDA
30/100
ALLOPURINOL
allopurinol
LOE Approaching
Teva
ORAL · TABLET
leukemialymphoma
1984
NDA
30/100
← PreviousPage 8 of 277Next →